Gefitinib for Patients with Incurable Cutaneous Squamous Cell Carcinoma A Single Arm Phase II Clinical Trial

BACKGROUND: Pre-clinical data demonstrate a key role for the epidermal growth factor receptor (EGFR) in the carcinogenesis of cutaneous squamous cell carcinomas (CSCC). There is, however, limited data on the efficacy of EGFR inhibitors in incurable, recurrent and/or metastatic CSCC. OBJECTIVE: To de...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Am Acad Dermatol
Main Authors: William, William N., Feng, Lei, Ferrarotto, Renata, Ginsberg, Lawrence, Kies, Merrill, Lippman, Scott, Glisson, Bonnie, Kim, Edward S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685879/
https://ncbi.nlm.nih.gov/pubmed/28964539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2017.07.048
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados